From Fermentation to Vaccination: Non-Animal Origin Squalene for High-Risk Applications

Monday, November 10, 2025

3:00 PM - 4:00 PM CT

Location:360 Stage #1, Exhibit Hall

Sponsored By

Partner Presentation Speaker(s)

SH

Supriyadi Hafiz

Senior Scientist
MilliporeSigma
Darmstadt, Hessen, Germany
PR

Priyanka Ram

Strategic Product Manager
MilliporeSigma
Burlington, Massachusetts

Description: This presentation highlights the growing demand for responsibly sourced alternatives to traditional animal-derived ingredients, focusing on fermentation-derived non-animal-origin (NAO) squalene. It addresses the significant environmental concerns associated with sourcing squalene from shark liver oil and explores how NAO squalene can serve as a sustainable alternative, particularly in vaccine adjuvant formulation.

Learning Objectives:

Understand the environmental impact of sourcing squalene from shark liver oil.
Explore the benefits of fermentation-derived non-animal-origin squalene as an alternative.
Evaluate the effectiveness of fermentation-derived squalene compared to traditional sources in vaccine formulations